Vimarsana
Biggest News Aggregation in the World

Multimodality Approaches News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Multimodality Approaches. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Multimodality Approaches Today - Breaking & Trending Today

Kazia Therapeutics Limited: KAZIA THERAPEUTICS REPORTS PROMISING INTERIM DATA FROM COMBINATION STUDY OF PAXALISIB WITH RADIOTHERAPY IN TREATMENT OF BRAIN METASTASES - Vimarsana News

Kazia Therapeutics Limited: KAZIA THERAPEUTICS REPORTS PROMISING INTERIM DATA FROM COMBINATION STUDY OF PAXALISIB WITH RADIOTHERAPY IN TREATMENT OF BRAIN METASTASES

Published: August 5, 2022

SYDNEY, Aug. 5, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce the presentation of promising new

Source: finanznachrichten.de
Related Topics:
New YorkUnited StatesMemorial Sloan Kettering Cancer CenterNew South WalesJonathan YangJames GarnerJane LoweHardestyp NakajiJoe GreenT Jonathan YangIain RossPrnewswire Kazia Therapeutics LimitedAmerican Society For Clinical OncologySociety For NeuroIr DepartmentKazia Therapeutics LimitedInternational TowersKazia TherapeuticsTherapeutics LimitedBrain MetastasesAmerican SocietyClinical OncologyMetastatic DiseaseRadiation OncologyPrincipal Investigator
KAZIA THERAPEUTICS REPORTS PROMISING INTERIM DATA FROM COMBINATION STUDY OF PAXALISIB WITH RADIOTHERAPY IN TREATMENT OF BRAIN METASTASES - Vimarsana News

KAZIA THERAPEUTICS REPORTS PROMISING INTERIM DATA FROM COMBINATION STUDY OF PAXALISIB WITH RADIOTHERAPY IN TREATMENT OF BRAIN METASTASES

Published: August 5, 2022

/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce the presentation of...

Source: prnewswire.com
Related Topics:
New YorkUnited StatesMemorial Sloan Kettering Cancer CenterNew South WalesJonathan YangJames GarnerJane LoweHardestyp NakajiJoe GreenT Jonathan YangIain RossAmerican Society For Clinical OncologySociety For NeuroIr DepartmentKazia Therapeutics LimitedInternational TowersKazia TherapeuticsBrain MetastasesAmerican SocietyClinical OncologyMetastatic DiseaseRadiation OncologyPrincipal InvestigatorStudy RationaleMultimodality Approaches